This perspective describes industry advances that highlight progress in the adoption of systems biology tools in drug development. Recent announcements from pathway analysis software vendors describe efforts to integrate pathway analysis tools with other established drug development tools, including chemical databases and associated analytics, high-throughput data analysis and manipulation tools, workflow analytics, and data visualization tools. These announcements signal a move toward improving access to pathway analysis tools and more seamless integration of these tools into the overall drug development process.